Lung Cancer News

Community-dwelling older adult smokers for whom annual low-dose CT screening is not recommended had a 10-fold higher risk for lung cancer compared with never smokers, according to study results.

New lung cancer screening guidance from the U.S. Preventive Services Task Force, which lowered the age for inclusion and intensity of smoking to qualify as high risk, resulted in an increase in the proportion of Black individuals screened.

CHICAGO — Adagrasib demonstrated promising efficacy for pretreated patients with advanced or metastatic non-small cell lung cancer who harbor KRASG12C mutations, according to study results presented at ASCO Annual Meeting.

Both visual and quantitative CT assessments of emphysema were associated with greater odds of lung cancer, researchers reported in Radiology.

CHICAGO — Chemoimmunotherapy and immunotherapy alone conferred comparable benefit as first-line therapy for most patients with advanced non-small cell lung cancer and high PD-L1 expression, results presented at ASCO Annual Meeting showed.

CHICAGO — A new combination therapy benefitted certain patients with immunotherapy-resistant advanced non-small cell lung cancer, according to randomized phase 2 study results presented at ASCO Annual Meeting.

The inclusion of a smoking cessation tool into electronic health records increased self-reported patient quit rates by more than 5 percentage points, according to study results.

A substantial proportion of patients with resected early non-small cell lung cancer who consented to an adjuvant therapy screening trial did not receive adequate lymph node dissection or adjuvant chemotherapy, according to study results.

A randomized phase 3 trial designed to evaluate tiragolumab plus atezolizumab for certain patients with advanced lung cancer failed to meet its co-primary endpoint of PFS, topline data showed.

Esophageal-sparing intensity-modulated radiotherapy did not significantly improve esophageal quality of life but reduced incidence of symptomatic esophagitis among patients with advanced non-small cell lung cancer.